Pacira BioSciences, Inc. v. QuVa Pharma, Inc.

  1. August 26, 2024

    Rival Can't Avoid Drugmaker's False Ad Claim Over Pain Med

    A Texas federal magistrate on Monday advised against dismissing Pacira Biosciences Inc.'s suit against a rival, finding that Pacira had alleged enough facts to show QuVa Pharma Inc.'s advertising is deceptive in a suit over the former company's compounded drug for pain.

  2. November 03, 2023

    Pacira Hits Rivals With False Ad Suits Over Pain Drugs

    Pharmaceutical company Pacira BioSciences Inc. is looking to stop rivals from marketing their so-called generic versions of its non-opioid based drug used to manage post-surgery pain, claiming in three separate lawsuits that the companies falsely advertise their medications as qualifying for an exemption to federal regulatory approval.